Clindamycin Phosphate Injection, Solution
Product Images NDC 0338-9553

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Clindamycin Phosphate (NDC 0338-9553). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clindamycin Structural Formula (Image 01)

Chemical structure diagram of clindamycin phosphate, showing its molecular components and bonds as related to the active ingredient clindamycin phosphate used in injection solutions.*

FDA Label Image

Clindamycin In Sodium Chloride Representative Container Label Ndc 0338-9545-50 (Image 02)

Clindamycin Phosphate 300 mg per 50 mL (6 mg/mL) injection, solution in 0.9% Sodium Chloride, labeled for intravenous infusion only. Single-dose 50 mL GALAXY container by Baxter Healthcare Company. Sterile and nonpyrogenic, with instructions to store at controlled room temperature and discard unused portion.*

FDA Label Image

Clindamycin In Sodium Chloride Representative Carton Label Ndc 0338-9545-24 1 Of 3 (Image 03)

Label section displaying a barcode position placeholder and a barcode number on a pink background. The label does not include product-specific information other than the barcode data.*

FDA Label Image

Clindamycin In Sodium Chloride Representative Carton Label Ndc 0338-9545-24 2 Of 3 (Image 04)

Packaging label for Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 300 mg per 50 mL (6 mg/mL) intravenous solution. The label shows the product name, concentration, dosage form, storage instructions, and manufacturer Baxter Healthcare Corporation, Deerfield, IL, USA. It also indicates the package contains twelve 50 mL single-dose containers.*

FDA Label Image

Clindamycin In Sodium Chloride Representative Carton Label Ndc 0338-9545-24 3 Of 3 (Image 05)

Label for clindamycin phosphate injection, solution for intravenous infusion, USP equivalent to 300 mg clindamycin per 50 mL. The label states it is sterile, nonpyrogenic, and includes details about inactive ingredients and cautions. The labeler is Baxter Healthcare Company. The NDC code 0338-9545-24 and barcode positioning instructions are visible.*

FDA Label Image

Clindamycin In Sodium Chloride Representative Container Label Ndc 0338-9549-50 (Image 06)

Clindamycin phosphate 300 mg/50 mL injection solution labels for intravenous use. The labels display storage instructions at 20°C to 25°C (68°F to 77°F), caution against temperatures above 30°C, and include lot number, expiration date, and serial number fields. The product is labeled by Baxter Healthcare Company and identified with NDC 0338-9545-24.*

FDA Label Image

Clindamycin In Sodium Chloride Representative Carton Label Ndc 0338-9549-24 1 Of 3 (Image 07)

Label for clindamycin phosphate in 0.9% sodium chloride injection, 600 mg per 50 mL (12 mg/mL), delivered as a 50 mL single dose GALAXY container by Baxter Healthcare Company. The solution is sterile and nonpyrogenic for intravenous infusion only, with storage instructions and cautionary statements included.*

FDA Label Image

Clindamycin In Sodium Chloride Representative Carton Label Ndc 0338-9549-24 2 Of 3 (Image 08)

A pink label for clindamycin phosphate injection solution, showing a barcode position area with the text 'BAR CODE POSITION ONLY' and a numeric barcode placeholder '303380549505'. The label is associated with Baxter Healthcare Company for intravenous use, with available strengths of 300 mg/50 mL, 600 mg/50 mL, and 900 mg/50 mL.*

FDA Label Image

Clindamycin In Sodium Chloride Representative Carton Label Ndc 0338-9549-24 3 Of 3 (Image 09)

Label for clindamycin phosphate 600 mg/50 mL injection, solution for intravenous use, in 0.9% sodium chloride. The label shows the product contains twelve 50 mL single dose containers. It is labeled by Baxter Healthcare Company, Deerfield, IL, USA. Storage instructions specify controlled room temperature 20°C to 25°C (68°F to 77°F), avoiding temperatures above 30°C.*

FDA Label Image

Clindamycin In Sodium Chloride Representative Container Label Ndc 0338-9553-50 (Image 10)

Label for clindamycin phosphate injection, solution, 600 mg/50 mL strength, for intravenous infusion only. The label includes dosage form, sterility, nonpyrogenic status, and cautionary statements about supplementary medication and use. Labeler is Baxter Healthcare Company. The image shows two identical vial or bag labels featuring NDC 0338-9549-24 and code 2G3456.*

FDA Label Image

Clindamycin In Sodium Chloride Representative Carton Label Ndc 0338-9553-24 1 Of 3 (Image 11)

Label for Clindamycin Phosphate 600 mg/50 mL in 0.9% Sodium Chloride Injection, an intravenous solution. The label includes storage instructions, lot number, expiration date, and serial number fields. Manufactured by Baxter Healthcare Corporation. NDC 0338-9549-24 with code 2G3456, Rx only.*

FDA Label Image

Clindamycin In Sodium Chloride Representative Carton Label Ndc 0338-9553-24 2 Of 3 (Image 12)

Label for Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 900 mg per 50 mL (18 mg/mL) in a 50 mL single dose GALAXY container. Sterile and nonpyrogenic, intended for intravenous infusion only. Manufactured by Baxter Healthcare Company. Includes cautions, storage instructions, and components details.*

FDA Label Image

Clindamycin In Sodium Chloride Representative Carton Label Ndc 0338-9553-24 3 Of 3 (Image 13)

Label showing the barcode position for clindamycin phosphate injection solution, intended for intravenous use. The label includes a barcode placeholder and a numeric code, with a light pink background.*

FDA Label Image

Image 14

Label for Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 900 mg per 50 mL (18 mg/mL) intravenous solution. Packaging indicates 12 single-dose 50 mL containers. Manufactured by Baxter Healthcare Corporation, Deerfield, IL, USA. Storage instructions specify controlled room temperature (20°C to 25°C).*

FDA Label Image

Image 15

Text panel for clindamycin phosphate injection, solution, USP equivalent to 900 mg clindamycin per 50 mL. It states the composition including sodium chloride, edetate disodium dihydrate, and water for injection, with pH adjustments. The label specifies intravenous infusion use only, cautions against adding supplementary medication and using in series connections, and advises checking for leakage and solution clarity. Labeler is Baxter Healthcare Company.*

FDA Label Image

Image 16

Label for Clindamycin Phosphate 900 mg/50 mL intravenous injection in 0.9% Sodium Chloride Injection, manufactured by Baxter Healthcare Company. The label includes storage instructions, lot number, expiration date, serial number, and the NDC 0338-9553-24. It is marked as Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.